These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6735094)

  • 41. Controlled trial of arbaprostil in bleeding peptic ulcer.
    Lauritsen K; Laursen LS; Havelund T; Bytzer P; Rask-Madsen J
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1093. PubMed ID: 3931810
    [No Abstract]   [Full Text] [Related]  

  • 42. Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2.
    Goldin E; Rachmilewitz D
    Dig Dis Sci; 1983 Sep; 28(9):807-11. PubMed ID: 6136395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and efficacy of Neodymium-Yag laser photocoagulation: an experimental study in dogs.
    Rutgeerts P; Vantrappen G; Geboes K; Broeckaert L
    Gut; 1981 Jan; 22(1):38-44. PubMed ID: 7193164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastric mucosal dissection using the Nd-YAG laser synthetic sapphire crystal contact probe. Development of an endoscopic method for the treatment of pancreatic pseudocysts.
    ReMine SG; Setzer SE; Shapshay SM
    Am Surg; 1988 Feb; 54(2):78-80. PubMed ID: 3341649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostaglandins and chemotherapy-induced ulcers in dogs.
    Bright-Asare P; Giannikopoulos I; Whiten JT
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):201S-203S. PubMed ID: 2932323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
    Steel G; Wallace JL; Whittle BJ
    Br J Pharmacol; 1987 Feb; 90(2):365-71. PubMed ID: 3470106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.
    Robert A; Kane G; Reele SB
    Gut; 1981 Sep; 22(9):728-31. PubMed ID: 7297921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chronic gastric ulcer in a child with Glanzmann thrombasthenia. Usefulness of prostaglandin E2].
    Calva-Rodríguez R; Mejía-Domínguez AM; Pandzich-Arapov S
    Bol Med Hosp Infant Mex; 1990 Sep; 47(9):653-5. PubMed ID: 2125426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hemostatic effects of the argon laser on the gastric wall of the dog. II. Effects of the laser on 53 hemorrhagic ulcers of the gastric mucosa].
    Le Bodic L; Le Bodic MF; Sudry P; Lemort J; Joubert B
    Ann Anat Pathol (Paris); 1979; 24(2):111-24. PubMed ID: 393136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Argon laser photocoagulation in the dog stomach.
    Bown SG; Salmon PR; Kelly DF; Calder BM; Pearson H; Weaver BM; Read AE
    Gut; 1979 Aug; 20(8):680-7. PubMed ID: 573722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arbaprostil in bleeding peptic ulcer.
    Joseph Sister
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1648. PubMed ID: 2934110
    [No Abstract]   [Full Text] [Related]  

  • 53. [Yag laser photocoagulation and monopolar electrohydrocoagulation: randomized study of the hemostatic effect on experimental hemorrhagic ulcer in dogs].
    Escourrou J; Balas D; Delvaux M; Hajjar A; Bertrand C; Frexinos J; Ribet A
    Gastroenterol Clin Biol; 1985 Mar; 9(3):212-9. PubMed ID: 3891490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
    J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the effects of prostacyclin and the 15(S), 15-methyl analogs of PGE2 and PGF2-alpha on gastric parietal and nonparietal secretion.
    Shea-Donohue PT; Nompleggi D; Myers L; Dubois A
    Dig Dis Sci; 1982 Jan; 27(1):17-22. PubMed ID: 7040000
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of 16,16-dimethyl PGE2 on renal papillary necrosis and gastrointestinal ulcerations (gastric, duodenal, intestinal) produced in rats by mefenamic acid.
    Elliott G; Whited BA; Purmalis A; Davis JP; Field SO; Lancaster C; Robert A
    Life Sci; 1986 Aug; 39(5):423-32. PubMed ID: 3736334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin protection against hemorrhage-induced gastric stress ulceration in the rat.
    Ranta-Knuuttila T; Kiviluoto T; Hyvärinen H; Lehtola A; Kivilaakso E
    Dig Dis Sci; 1989 Jul; 34(7):1028-34. PubMed ID: 2743842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Anti-ulcerogenic and cytoprotective effects of trimoprostil (Ro 21-6937), a trimethylprostaglandin E2 derivative].
    Ohno T; Yamaguchi Y; Yajima T; Nakamura K
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):131-47. PubMed ID: 6607197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
    Konturek SJ; Radecki T; Piastucki I; Brzozowski T; Drozdowicz D
    Gut; 1987 Feb; 28(2):201-5. PubMed ID: 3470240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.